Benzinga | Dec 21, 2021 09:58AM EST

JP Morgan Maintains Neutral on Novavax, Raises Price Target to $209

JP Morgan analyst Eric Joseph maintains Novavax (NASDAQ:NVAX) with a Neutral and raises the price target from $172 to $209.